208 related articles for article (PubMed ID: 15287885)
1. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
3. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
4. A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage.
Lai MT; Crouthamel MC; DiMuzio J; Pietrak BL; Donoviel DB; Bernstein A; Gardell SJ; Li YM; Hazuda D
J Neurochem; 2006 Jan; 96(1):118-25. PubMed ID: 16300640
[TBL] [Abstract][Full Text] [Related]
5. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
[TBL] [Abstract][Full Text] [Related]
6. Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein.
Laudon H; Mathews PM; Karlström H; Bergman A; Farmery MR; Nixon RA; Winblad B; Gandy SE; Lendahl U; Lundkvist J; Näslund J
J Neurochem; 2004 Apr; 89(1):44-53. PubMed ID: 15030388
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?
Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW
Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205
[TBL] [Abstract][Full Text] [Related]
8. New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage.
Petit A; Bihel F; Alvès da Costa C; Pourquié O; Checler F; Kraus JL
Nat Cell Biol; 2001 May; 3(5):507-11. PubMed ID: 11331880
[TBL] [Abstract][Full Text] [Related]
9. Neprilysin activity and expression are controlled by nicastrin.
Pardossi-Piquard R; Dunys J; Yu G; St George-Hyslop P; Alves da Costa C; Checler F
J Neurochem; 2006 May; 97(4):1052-6. PubMed ID: 16606360
[TBL] [Abstract][Full Text] [Related]
10. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
11. PEN-2 enhances gamma-cleavage after presenilin heterodimer formation.
Shiraishi H; Sai X; Wang HQ; Maeda Y; Kurono Y; Nishimura M; Yanagisawa K; Komano H
J Neurochem; 2004 Sep; 90(6):1402-13. PubMed ID: 15341524
[TBL] [Abstract][Full Text] [Related]
12. Release of a membrane-bound death domain by gamma-secretase processing of the p75NTR homolog NRADD.
Gowrishankar K; Zeidler MG; Vincenz C
J Cell Sci; 2004 Aug; 117(Pt 18):4099-111. PubMed ID: 15280425
[TBL] [Abstract][Full Text] [Related]
13. Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and gamma-secretase activity.
Brunkan AL; Martinez M; Wang J; Walker ES; Beher D; Shearman MS; Goate AM
J Neurochem; 2005 Sep; 94(5):1315-28. PubMed ID: 16001967
[TBL] [Abstract][Full Text] [Related]
14. Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway.
Lopez-Perez E; Seidah NG; Checler F
J Neurochem; 1999 Nov; 73(5):2056-62. PubMed ID: 10537065
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
16. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
17. Presenilin function and gamma-secretase activity.
Brunkan AL; Goate AM
J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
[TBL] [Abstract][Full Text] [Related]
18. Distinct presenilin-dependent and presenilin-independent gamma-secretases are responsible for total cellular Abeta production.
Wilson CA; Doms RW; Lee VM
J Neurosci Res; 2003 Nov; 74(3):361-9. PubMed ID: 14598312
[TBL] [Abstract][Full Text] [Related]
19. Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage.
Qyang Y; Chambers SM; Wang P; Xia X; Chen X; Goodell MA; Zheng H
Biochemistry; 2004 May; 43(18):5352-9. PubMed ID: 15122901
[TBL] [Abstract][Full Text] [Related]
20. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.
Herreman A; Serneels L; Annaert W; Collen D; Schoonjans L; De Strooper B
Nat Cell Biol; 2000 Jul; 2(7):461-2. PubMed ID: 10878813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
